MasTec, Inc. (MTZ)
Last Price$127.7(2.2%)
Market Cap$10.2B
MTZ Rating
MTZ Quality rating performance
MTZ Intrinsic Value
Key Highlights:
As of Mar 03, 2025 MTZ Relative Value is $520.4, which is undervalued by 307.6%, compared to current share price of $127.7.
As of Mar 03, 2025 MTZ DCF Value is $360.5, which is undervalued by 182.3%, compared to current share price of $127.7.
MTZ Share Price History
1W 1.7%
1M (9.8%)
6M 22.3%
YTD 72.2%
1Y 45.6%
3Y 66.1%
5Y 159.0%
10Y 498.3%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
MTZ Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$10.2B
$10.4B
$12.3B
$549.4M
Shares Outstanding
80M
Employees
N/A
Growth (CAGR)
11.4%
(1.3%)
(16.70%)
Profitability
11.0%
4.5%
5.3%
4.5%
559.4%
Intrinsic Value
$432.9 (239.1% undervalued)
$357.4
$508.5
($1,195.5)
39.7%
Return on Capital
Financial Health
$261.3M
0.5x
2.9x
Dividends
Earnings
Apr 30, 2025
MISS by (2.2%)
BEAT by 24.5%
27.3%
8 Beat & 2 Miss
MTZ Stock Financials
MTZ Income Statement Metrics
Annual
Quarterly
LTM
MTZ Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$687.3M +95.1% YoY
Capital Expenditure (CAPEX)
($192.9M) -26.7% YoY
Free Cash Flow (FCF)
$494.3M +455.8% YoY
MTZ Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$12.0B 22.7% YoY
Cost of revenue
$11.2B 30.5% YoY
Pre-tax income
$82.7M 0.0% YoY
(0.7%) margin
MTZ Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$9,373.5M
Current assets ($3,974.3M, 42.4% of total)
$529.6M (5.6%)
$3,126.5M (33.4%)
Other current assets
$318.2M (3.4%)
Non-current assets ($5,399.3M, 57.6% of total)
$0.0 (0.0%)
$2,070.1M (22.1%)
$784.3M (8.4%)
Other non-current assets
$2,544.8M (27.1%)
Financial position
$2,966.4M
Cash & Short-term
Investments
Total Debt
MTZ Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
MTZ Earnings Surprises
Crunching data... Almost there!
MTZ Dividends
MTZ Dividend Yield
Crunching data... Almost there!
MTZ Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with MTZ
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$10.2B | 5.3 | $432.9 239.1% undervalued | 45.6% | $12.3B | $549.4M | 2.6% | 4.5% | 11.0% | 8.9% | 8.7% | |
$38.1B | 6.6 | $196.7 21.6% overvalued | 3.2% | $23.7B | $1,477.1M | 13.4% | 6.2% | 14.0% | 7.2% | 5.2% | |
$18.7B | 7.2 | $402.5 1.7% undervalued | 22.5% | $14.6B | $1,332.9M | 15.8% | 9.2% | 19.0% | 19.3% | 24.0% | |
$17.5B | 5.7 | $137.9 10.2% undervalued | 2.5% | $14.4B | $629.6M | (13.9%) | 4.4% | 22.4% | 12.7% | 72.1% | |
$13.1B | 6.2 | $66.9 31.1% overvalued | 9.2% | $16.2B | $772.2M | 8.9% | 4.8% | 6.8% | 16.8% | 136.6% | |
$12.9B | 7.8 | $300.2 13.1% overvalued | 8.3% | $7,027.5M | $738.0M | 35.0% | 10.5% | 20.6% | 18.8% | 3.7% | |
$10.6B | 5.7 | $22.9 38.8% overvalued | (2.6%) | $7,018.0M | $536.0M | 1.3% | 7.6% | 29.5% | 6.2% | 0.1% | |
$9,711.1M | 5.2 | $53.2 36.5% overvalued | 2.6% | CA$7,500.0M | CA$523.9M | 15.7% | 7.0% | 40.5% | 6.8% | 69.4% | |
$8,904.3M | 6.8 | $394.5 33.2% undervalued | (26.8%) | $5,329.8M | $706.7M | 2.6% | 13.3% | 30.5% | 17.3% | 71.4% | |
$7,766.4M | 5.8 | $30.2 6.9% undervalued | (22.6%) | $5,391.0M | $344.4M | 11.0% | 6.4% | 16.6% | 9.7% | 64.1% | |
$6,511.9M | 6.3 | $102.6 177.9% undervalued | 0.9% | $16.3B | $664.0M | 5.4% | 4.1% | 3.5% | (17.5%) | 27.7% |
FAQ
What is MasTec, Inc. (MTZ) stock rating?
As of today, MasTec, Inc. has a stock rating of 5 (out of 10), which is considered Good.
is MasTec, Inc. (MTZ) a good stock to buy?
As of today, MasTec, Inc. has a Good stock rating, which is 239.1% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.